GSK PLC GSK
News
GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX
Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk
ITeos Therapeutics Shares Rise on Positive Data From Lung Cancer Study
GSK Bets on Blood-Cancer Drug Comeback Amid Oncology Push
GSK's mRNA Flu Vaccine Advances to Late-Stage Clinical Development After Positive Trial Results
GSK Reaches Another Settlement in Zantac Litigation
GSK Says Herpes Vaccine Candidate Study Failed to Meet Primary Objective
Zenas BioPharma, Bicara Therapeutics sets IPO price ranges as summer lull ends
GSK's Asthma Treatment Shows Positive Results for Chronic Obstructive Pulmonary Disease
GSK shares jump on win in Delaware court over ongoing Zantac battle
5 things you need to know about COVID, flu and RSV vaccines this fall
GSK Wins Zantac Cancer Lawsuit in Florida
US FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit
GSK's better-than-expected results overshadowed by Zantac litigation
GSK Lifts Guidance After HIV, Cancer Treatments Boost Sales — Update
GSK Enters Partnership With Flagship Pioneering to Develop Up to 10 New Drugs
GSK Reaches Another Settlement Over Individual Heartburn Drug Lawsuit
GSK Begins Shipping Influenza Vaccine Doses for 2024-25 Season
CureVac's stock soars on GSK's $1.56 billion deal for its COVID-19 and flu vaccines